Trulieve repays USD 65 million mortgage. Cantor targets Trulieve stock at USD 15.00
Published on 10/08/2026 at 13:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTrulieve (ISIN US89790E1064) was trading at EUR 9.62 at Lang & Schwarz on October 8, 2026 at 1:37 p.m. CEST, down 0.82 percent versus the prior close of EUR 9.70. On October 7, 2026, Trulieve announced repayment of a USD 65 million mortgage, while Cantor Fitzgerald maintained a Buy rating and a USD 15.00 price target, as reported by Markets Insider on September 30, 2026.
Three dated company markers
On August 7, 2026, Trulieve reported second-quarter revenue of USD 270.95 million and a GAAP net loss of USD 406.06 million, according to Markets Insider. Revenue was USD 302.09 million in the year-earlier quarter, making the latest figure 10.31 percent lower.
On September 30, 2026, Cantor Fitzgerald kept its Buy rating and USD 15.00 target, according to Markets Insider. On October 7, 2026, Trulieve repaid the USD 65 million mortgage and reduced outstanding debt to USD 225 million, according to the company release.
What does the debt payment change?
The immediate balance-sheet effect is the removal of a USD 65 million mortgage before maturity. Trulieve said the repayment should lower annual interest expense and improve profitability and cash flow, while expansion in Georgia and Texas remains tied to regulatory approvals.
November 5 marks the next test
Trulieve is scheduled to release third-quarter 2026 results and hold its conference call on November 5, 2026 at 8:30 a.m. Eastern Time, according to StockTitan. That report will show how the company entered the third quarter before the mortgage repayment and whether operating cash generation supported the debt action.
EUR 9.62 in afternoon trading
At Lang & Schwarz, Trulieve was trading at EUR 9.62 on October 8, 2026 at 1:37 p.m. CEST, down 0.82 percent versus the prior close of EUR 9.70 on October 7, 2026. The NYSE 52-week range was USD 4.62 to USD 13.28 as of October 7, 2026, and market capitalization was USD 1.8 billion.
The further course of trading is shown by the continuously updated real-time quote of Trulieve stock.
Trulieve stock facts
- Company: Trulieve Cannabis Corp.
- ISIN: US89790E1064
- Ticker: TRLV
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 8, 2026, 1:37 p.m. CEST): EUR 9.62
- Change versus prior close: minus 0.82 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 9.70
- Market capitalization: USD 1.8 billion (as of October 7, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty & Generic
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
